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Introduction
Human immunodeficiency virus type 1 (HIV-1) infection in-
duces changes in the host cell transcriptome (Giri et al., 2006; 
Li et al., 2009) and proteome (Chan et al., 2007; Ringrose et al.,   
2008; Rasheed et al., 2009). Both biochemical studies and   
genome-wide short hairpin/siRNA screens have identified nucleo-
porins (Nups) as HIV-1 dependency factors that assist nuclear 
import of the preintegration complex (PIC; Ebina et al., 2004; 
Goff, 2008; König et al., 2008; Kok et al., 2009; Woodward   
et al., 2009; Yeung et al., 2009). Nups are also required for the 
nuclear export of viral factors during the late stages of HIV-1 
replication (Zolotukhin and Felber, 1999; Hofmann et al., 2001; 
Le Rouzic et al., 2002; Kiss et al., 2003; Hutten and Kehlenbach, 
2006; Hutten et al., 2009). Approximately 30 different Nups 
present in multiple copies and organized in an eightfold radial 
symmetry compose nuclear pore complexes (NPCs), which stud 
and span nuclear envelopes (NEs) and act as selective barriers 
for the nucleocytoplasmic shuttling of macromolecules (Wente   
and Rout, 2010). Hepatitis B virus, herpes simplex virus,   
influenza virus, and adenovirus also use Nups to access nuclei 
(Trotman et al., 2001; Copeland et al., 2009; König et al., 2010; 
Schmitz et al., 2010), whereas poliovirus and cardiovirus induce 
their rearrangement or degradation (Gustin and Sarnow, 2001, 
2002; Bardina et al., 2009; Porter and Palmenberg, 2009).
Studies using organellar proteomics can reveal proteins 
that are otherwise masked during whole cell analyses and pro-
vide information on protein localization and function, an espe-
cially useful tool for studying a virus that usurps many cellular 
machineries (Brunet et al., 2003; Gilchrist et al., 2006). This 
work extends our previous finding that HIV-1 replication im-
poses a blockade to the nuclear import of heterogeneous nuclear 
RNP A1 (hnRNP A1) and its transport receptor Transportin-1 
via alterations in the localization and abundance of Nup p62 
(Nup62; Monette et al., 2009). The persistence of Nup62 at the 
NPC core, where it authenticates passing cargo, depends on the 
surrounding scaffolding and anchoring Nups (Wente and Rout, 
2010). To determine whether the block in nuclear shuttling 
imposed by HIV-1 was limited to Nup62 expression or to the 
malfunctioning of other Nups, we undertook a proteomic study 
to compare the composition of purified NEs from mock- and 
HIV-1–infected Jurkat T cells. This has enabled the identifica-
tion of 413 NE-associated host proteins, with 68% showing signi-
ficant changes in abundance, among which many were those 
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Figure 1.  Procedure taken for isolating and verifying NEs from HIV-1–infected cells. (A) A diagram depicting the architecture of NEs with associated ER, 
nuclear lamina, and chromatin that were purified during the isolation procedure (indicated by scissors). (B) Western analysis of proteins isolated at each 
step of the NE purification method using mock ()- or minimally HIV-1 (+)–infected cells to show the elimination of plasma membrane (pr55
Gag and p24), 621 HIV-1 remodels the nuclear pore complex • Monette et al.
cytoplasmic (pr55
Gag and glyceraldehyde 3-phosphate dehydrogenase [GAPDH]), nuclear (chromatin-binding proliferating cell nuclear antigen [PCNA]), 
and nucleolar (Nucleolin) proteins and the enrichment of NE (Lamin B1), NPC (Nup62 and phenylalanine-glycine–Nups), and ER (Calnexin) proteins.   
(C) Stepwise IF analysis of HIV-1 Gag, Lamin B1 (LMNB1), and Nup62 with DAPI staining (top row) or DIC (bottom row) of isolated products. DIC shows 
all visible endpoint structures that stain positively for LMNB1 and Nup62. 3D renderings of z stacks are shown. Bars, 10 µm.
 
associated with NPCs. Immunogold EM revealed that at least 
one Nup is dislodged from NPCs and is redirected to budding 
virions.  Immunofluorescence  (IF)  experiments  suggest  that 
Nup62 is essential for viral genomic RNA (vRNA) export and 
may take leave of NPCs as part of the growing HIV-1 vRNA–
RNP complex, where it may ensure its replicative success dur-
ing viral egress, gene expression, and assembly.
Results and discussion
Isolation of NEs from HIV-1–infected T cells
To define changes to NPC composition in HIV-1–infected   
T cells, we used a recently published method to isolate NEs and 
accompanying NPCs, associated nuclear lamina, and contigu-
ous ER from T cells for a comparative liquid chromatography 
(LC)/tandem mass spectrometry (MS/MS) study (Fig. 1 A;   
Korfali et al., 2009). Because much of the starting material is 
lost from the purification procedure, we first tested the method 
for its ability to enrich NEs by collecting cellular products iso-
lated at each step of the procedure from mock- or lowly infected 
cells (day 3 after transfection of proviral DNA). These were 
normalized  for  protein  content  and  loaded  onto  SDS-PAGE 
gels for Western analysis, which validated the purification 
procedure of NEs from cells by highlighting the gradual loss 
of plasma membrane–associated viral (e.g., p24 Capsid [CA] 
and pr55
Gag), cytoplasmic (e.g., pr55
Gag and glyceraldehyde 3-
phosphate dehydrogenase), and chromatin-binding and nuclear 
proteins (e.g., proliferating cell nuclear antigen and Nucleolin) 
and the accompanying enrichment of NE, NPC, and ER pro-
teins Lamin B1, Nup, and Calnexin, respectively (Fig. 1 B). To 
further validate the method, again, at low infection stages (day 3) 
mirrored by only two cells labeled by the anti-Gag antibody 
(Fig. 1 C, top row, first panel), products from each step of the 
procedure were analyzed by IF. The staining for NE-associated 
Lamin B1 and the decrease in DAPI staining demonstrate the 
enrichment in NE proteins and the removal of the majority of 
chromosomal DNA contaminants, respectively (Fig. 1 C, top 
row). In addition, differential interference contrast (DIC) con-
firmed that all visible endpoint structures from NE preparations 
were immunopositive for Nup62 and Lamin B1 (Fig. 1 C, 
bottom row).
Satisfied with the successful isolation of NEs, we next 
repeated the procedure using mock- or peak-infected T cells. 
Western analysis identified viral proteins from peak-infected 
whole cell lysates but not from NEs derived from peak-infected 
cells deficient in plasma membrane, cytoplasmic, and nuclear 
proteins and enriched with NE and NPC proteins (Fig. 2 A). 
Importantly, and as previously observed in our earlier work, 
Nup62 levels were reduced in peak-infected whole cells (Fig. 2 A,   
left; Monette et al., 2009), and this reduction was also appar-
ent in NEs isolated from these cells (Fig. 2 A, right). As an 
additional control to verify peak-infected cell populations, 
coimmunostaining for Gag and cleaved Caspase-3 revealed 
that <1% (n = 5,000) of cells was apoptotic at peak infection   
(Fig. 2 B). Protein gels were stained, and gel slices were excised 
for LC-MS/MS analysis (Fig. 2 C). Mascot server–generated   
exponentially modified protein abundance index (emPAI) values 
for individual proteins were used to calculate how HIV-1 infection 
affects their abundance at NEs (Table S3, last column). Globally, 
HIV-1 infection dramatically impacted NE protein composition 
by increasing or decreasing total protein abundance by 38 and 
30%, respectively (Fig. 2 D). The classification of protein hits 
into Gene Ontology (GO)–term biological processes, and the 
means of their cumulative emPAI values provided evidence that 
proteins involved in cell division, differentiation, and DNA re-
pair were less prevalent in NEs from infected cells (Fig. 2 E).   
Other  down-regulated  processes  included  protein  secretion, 
posttranslational modification, translation regulation, stress re-
sponse, immune response, and nucleocytoplasmic shuttling, all 
of which might otherwise elicit an antiviral state. Conversely, 
proteins participating in T cell activation and vesicular traf-
ficking were up-regulated, as were nucleosomal, transcription, 
RNA-binding, processing, splicing, and ribosomal proteins, 
suggesting that HIV-1 has far-reaching effects on nuclear events 
that may contribute to its replicative success. In support of this, 
when protein hits were organized according to subcellular com-
partments, those known to be important for HIV-1 replication, 
such as chromosomal and vesicular proteins, were found to be 
up-regulated (Fig. 2 F). Importantly, proteins involved in nucleo-
cytoplasmic transport were most underrepresented, and this 
was reflected by a lowered abundance of nuclear and nuclear 
membrane–associated  proteins.  Our  observation  that  HIV-1 
infection affects the expression of nucleocytoplasmic shuttling 
proteins is reflected by earlier studies using CD4
+ and primary 
cells (Chan et al., 2007, 2009). Although Chan et al. (2007, 
2009) used whole cells for their analysis, >46% of the com-
mon hits are modified in the same direction by HIV-1 infection   
(Table I). In all, we find that 54, 100, 100, and 50% of our iden-
tified Nups, importins, Ran GTP–GDP cycle, and hnRNP pro-
teins, respectively, are modified in the same direction by HIV-1 
infection, lending additional support to our virological methods 
and use of emPAI values to report our findings (Table I). More 
recently, several Nups and importins were found to be decreased 
by human respiratory syncycial virus infection (Munday et al., 
2010), and it has been speculated that the blocking of nuclear 
import may be a common feature of infections by RNA viruses 
(Gustin, 2003).
HIV-1 disperses Nups into the cytoplasm 
and into progeny virus
The most salient effect induced by HIV-1 infection was on the 
abundance of NPC proteins with observed decreases of 18 of JCB • VOLUME 193 • NUMBER 4 • 2011   622
Figure 2.  Verification of the purity of isolated NEs, the apoptosis levels of peak-infected T cells, and GO analysis of LC-MS/MS–identified NE-associated 
proteins. (A) Western analysis of whole cell lysates and purified NEs in mock- and peak-infected cells. (B) IF for Gag and cleaved Caspase-3 (apoptosis 
marker) and DIC in peak-infected cells. Less than 1% of cells was apoptotic. 3D renderings of z stacks are shown. Bar, 10 µm. (C) Coomassie blue–stained 
SDS-PAGE of whole cell and purified NEs for LC-MS/MS. Scissors demarcate excised gel plugs. (D) A scatterplot of all NE-associated proteins identified 
by LC-MS/MS. Increases and decreases are shown in green and red. (E and F) NE-associated proteins are identified and organized according to GO 
UniProt/SwissProt biological processes (E) or subcellular compartments (F).623 HIV-1 remodels the nuclear pore complex • Monette et al.
the 30 main Nups. Therefore, thin-section transmission EM 
was performed to evaluate the integrity of NEs and NPCs from 
mock- or pNL4-3–transfected HeLa cells, but no detectable dif-
ferences in these nanostructures between samples could be seen 
(Fig. 3 A). However, when immunogold EM was performed 
using two different phenylalanine-glycine–rich Nup-specific 
antibodies (i.e., mab414 and QE5), whereas Nup labeling was 
specifically and predominantly associated with the NPCs of 
mock-transfected cells (Fig. 3, B and C, left), analysis of the 
distribution of Nups in HIV-1–expressing cells (identified by 
a budding virus at the plasma membranes) showed them to be 
dispersed  throughout  the  cytoplasm  and  in  budding  viruses 
(Fig. 3, B and C, right). Lamin B2 labeling, used as a control, 
remained associated with NEs (unpublished data). Quantita-
tive software-assisted measurements of the distance between 
mab414/QE5 immunogold labeling and the inner nuclear mem-
brane confirmed a fivefold increase in HIV-1–infected cells   
(n = 459, mock; n = 498, HIV-1 expressing). Double immuno-
gold labeling with anti–CA p24 and QE5 or mab414 antibodies   
colabeled budding viruses (Fig. 3 D). Though mab414 most 
readily recognizes Nup62 as well as other Nups, Western blot-
ting analysis revealed that Nup62 was selectively incorporated 
in the virus (Fig. 3 E).
In  untransfected  cells,  Nup62  localizes  exclusively  to 
NEs. However, HIV-1 induces the translocation of Nup62 to the 
cytoplasm  and  plasma  membrane  where  it  colocalizes  with 
Gag, indicating that Nup62 may be a resident of the vRNA–Gag 
complex as it traffics intracellularly (Fig. 4 A). Our earlier work 
suggested a tight correlation between Rev gene expression and 
the cytoplasmic retention of hnRNP A1 (Monette et al., 2009). 
Therefore,  to  identify  the  viral  gene  responsible  for  altered 
Nup62 distribution, we tested a battery of pNL4-3 mutants, and 
only Rev-deficient mutants failed to translocate Nup62 to the 
cytoplasm (Fig. 4 B and not depicted). We next examined 
whether Rev alone could recapitulate these findings. The over-
expression (OE) of Rev-RFP in mock-transfected cells was able 
to cause the thickened Nup62 staining at the NE but not its cyto-
plasmic localization (Fig. 4 C, top row). The OE of RFP empty 
vector control in Rev()-expressing cells did not affect Nup62 
staining, nor did it induce vRNA nuclear export (Fig. 4 C, middle 
panel).  However,  the  OE  of  Rev-RFP  with  Rev()  rescued 
vRNA nuclear export and elicited both the thickened NE stain-
ing and cytoplasmic translocation of Nup62 (Fig. 4 C, bottom 
panel). These results suggest that Nup62 becomes engaged with 
the vRNA before nuclear export. Colocalization analyses revealed 
that Nup62 localizes with Rev, the vRNA, and Gag (Fig. 4 A 
and not depicted), suggesting that they may be part of the same 
cytoplasmic RNP and, thus, supporting a cytoplasmic role for 
Nup62 (Hubert et al., 2009).
The observations that many Nups are decreased at NEs by 
HIV-1 infection and the reported interactions between Nups and 
the Rev–vRNA RNP (Hofmann et al., 2001) raise the possibil-
ity that this RNP may, during nuclear export, dislodge Nups 
essential for NPC integrity. This could lead to, among other 
things, the encapsidation of Nups in progeny virus (Fig. 4 D). 
Such a dismantling of the NPC could be possible because of the 
finding that two of the three anchoring Nups that we detected 
(i.e., Gp210 and Pom121) are decreased at the NE by HIV-1 
infection. Gp210 was validated by Western blotting in this 
study (unpublished data) and has also been identified as an HIV-1 
dependency factor (Kok et al., 2009).
The  results  presented  here  using  both  HIV-1–infected  T   
cells and pNL4-3–transfected CD4
 HeLa cells, along with the 
biochemical and physical evidence for virion-associated Nup62, 
Table I.  Comparison of NPC and shuttling proteins identified from LC-MS/MS studies
Type Down-regulated by HIV-1 Up-regulated by HIV-1











b KTN1, NUP43, NUP58, NUP45, 
NUP54, GP210, POM121, 
NUP107, NUP133, NUP155, 
NUP160, NUP37, NUP85, 
NUP93
KTN1, NUP43, NUP58/
NUP45, NUP54, NUP50, 
NUP62
NUP35, NUP98, TPR NUP35, NUP98, TPR, NUP153, 
NUP214, NUP93, POM121
Importins (100%) KNPB1, KPNA2 KPNB1, KPNA2, KPNA3, 
KPNA4, KPNA6, IPO5, IPO7, 





RANGAP1, RCC1 RANBP2(NUP358), 




Exportins RIP N/D NXF1 RIP, XPO1, XPO2, XPO5, XPO7
hnRNP proteins 
(50%)
HNRNPG, HNRNPK, HNRNPL, 
HNRNPR
HNRNPG, HNRNPF HNRNPA1, HNRNPA2, 
HNRNPC, HNRNPM, 
HNRNPU
HNRNPA1, HNRNPA2, HNRNPC, 
HNRNPM, HNRNPU, HNRNPH, 
HNRNPK, HNRNPL, HNRNPQ, 
HNRNPR
Boldface text indicates common proteins between studies that are modulated in a similar direction by HIV-1. Italicized proteins were found to be regulated in an   
opposite manner. N/D, not detected.
aMass spectrometry hits found in Chan et al. (2007) and/or Chan et al. (2009).
bQuantitative correspondence between this study and those of Chan et al. (2007, 2009).JCB • VOLUME 193 • NUMBER 4 • 2011   624
import, and its increased representation at NEs by HIV-1 suggests 
a safeguard to guarantee its persistence at the NPC. Nup98 has 
also been shown to be up-regulated in expression by interferons 
during the course of vesicular stomatitis virus infection to release 
the block on nuclear mRNA export (Enninga et al., 2002).
Further  support  pointing  to  the  late  replication  stages 
comes from the finding that newly synthesized Rev contributes 
indicate that NPC remodeling is induced by HIV-1 during the late 
replication stages. Further support for this comes from the observa-
tion that Nup358 is also decreased by HIV-1 (Fig. 4 D and Table I; 
Chan et al., 2007). Nup358 is required for the nuclear import of 
Rev, so it would be counterproductive to modulate NE levels early, 
resulting in a block in vRNA export (Hutten et al., 2009). Nup98, 
in contrast, is required for both Rev–vRNA RNP export and PIC 
Figure 3.  HIV-1 disperses Nups into the cyto-
plasm  and  progeny  virions.  (A)  Thin-section 
electron  micrographs  of  NE  cross  sections 
from mock- or pNL4-3–transfected HeLa cells.   
(B) Immunogold labeling of Nups using mab414 
antibody (10-nm gold labels; red arrowheads) 
in mock-transfected and in pNL4-3–expressing 
HeLa cells. (C) Immunogold labeling of Nups 
using the QE5 antibody (purple arrowheads). 
Nups associated with NEs in mock-transfected 
(91 ± 15.7%, SD) versus pNL4-3–transfected 
(32 ± 5.9%) cells; Nups within the cytoplasm 
in mock-transfected (8.9 ± 4.3%) versus pNL4-
3–transfected (68 ± 8.5%) cells. (D) Immuno-
gold labeling of budding virus for Gag (10- or 
15-nm gold labels; white arrowheads), QE5 
(10- or 15-nm gold labels; purple arrowheads), 
and mab414 (10-nm gold labels; red arrow-
heads).  Yellow  asterisks,  NPC;  PM,  plasma 
membrane; NE, nuclear envelope. (E) Western 
analysis for Gag and Nups in cell lysates and 
purified viruses collected from mock ()- and 
pNL4-3 (+)–transfected HeLa cells.625 HIV-1 remodels the nuclear pore complex • Monette et al.
Figure 4.  HIV-1 Rev–vRNA RNP nuclear export leads to the dispersal of Nup62. (A) Wild-type HIV-1 DNA–transfected HeLa cells were stained for vRNA, 
Gag, and Nup62. Nup62-Gag colocalization is shown in gray. (B) HeLa cells transfected with Rev() (R38Q) DNA and stained for vRNA and Nup62. 
3D renditions of z stacks with deconvolution (A and B) are shown. (C) HeLa cells were transfected as indicated in the figure: RFP and Rev-RFP (blue), vRNA 
(green), and Nup62 (red). Yellow arrowheads identify cells expressing Rev-RFP (top and bottom panels) or RFP alone (middle panel), and white arrowheads 
identify untransfected cells. (D) Color-coded effects on Nups by HIV-1 infection, as determined by LC-MS/MS of the NE. A predictive model is shown on 
how the Rev–vRNA RNP may displace Nups during nuclear export. Asterisk, unchanged or not detected. (E and F) Protein interaction maps for LC-MS/MS 
hits that are decreased (E) or increased (F) by HIV-1 infection. Bars, 10 µm.JCB • VOLUME 193 • NUMBER 4 • 2011   626
to the resistance to superinfection by binding to and exporting 
Integrase (Levin et al., 2010), introducing the possibility that if 
Nup-interacting proteins are exported as a single RNP, they may 
together negatively influence NPC integrity.
Based on the prediction that the export of the HIV-1 RNP 
leads to the loss of Nups from the NPC, we investigated the pos-
sibility that other NE-associated proteins may also be affected 
as a result of extensive protein–protein interaction networks. 
The  STRING  (Search  Tool  for  the  Retrieval  of  Interacting 
Genes/Proteins)  database  v8.3–generated  protein  interaction 
maps show that 76 and 69% of hits up- or down-regulated by 
HIV-1 interact with others within these categories (Fig. 4, E and F). 
This further suggests that proteins from micro or macro RNPs 
may move together toward or away from NEs and that this 
movement may be greatly enhanced by infection. We performed 
literature searches to show those of our hits that interact with 
viral proteins or with the vRNA in case transient interactions 
with viral proteins have effects on the abundance at the NEs 
(Table S1). HIV-1–interacting proteins most affected by infec-
tion are CBX1, CSNK2A1, KKBP11, NUMA1, PPIB, RCC1, 
PP1CA, SNRPD3, and XRCC5, and others that interact with the 
Rev–vRNA RNP are DHX9, HNRNPs, HRIP1, ILF3, MATR3, 
NPM1, and SR proteins. We then compared our hits with pro-
teins known to be encapsidated in case some have their RNP-
joining origins at NEs (Table S2). We found that a small set of 
our hits were encapsidated and that those most decreased at 
NEs were EEF1A1, HIST1H4, HSP90AB1, HSPA1L, KPNB1, 
and VIM. Hoping to accelerate the discovery of central partici-
pants of HIV-1 replication, we further refined our findings by 
performing literature searches to define those of our hits that 
had known functions during HIV-1 replication and that inhibit 
HIV-1 or have modified expression levels as a result of infection 
(Table S2). One potential caveat to our approach has been the 
necessity to use the Jurkat T cell line instead of primary cells 
because of the large amount of starting material required for the 
isolation of NEs. In addition, though the majority of our protein 
hits were those that could be associated in some way with NEs 
or with the ER, others are known to have entirely different cel-
lular roles and, therefore, may be contaminants arising from the 
isolation procedure. Therefore, the development of better strate-
gies for the isolation of subcellular compartments for minimal 
loss of specimens and preservation of intact organelles will help 
advance the important field of organellar proteomics (Gauthier 
and Lazure, 2008).
Nup62 is essential for HIV-1 vRNA export
Our results provide evidence that the Rev–vRNA RNP disrupts 
NPCs, leading to the cytoplasmic translocation of Nup62 and 
its encapsidation into virions. To determine whether Nup62 is 
essential for HIV-1 gene expression and infectivity, we used   
siRNAs to perform siRNA-mediated knockdown (KD) on Nup62 
in HeLa (CD4
) cells that were then transfected with mock 
or proviral DNA, and purified viruses produced by these cells 
were used to infect native HeLa–TZM-bl (CD4
+) cells. Western 
analysis revealed that a >82% Nup62 KD led to a substantial 
decrease in pr55
Gag and p24 CA, whereas the 60% Nup107 KD 
only modestly reduced p24 CA levels (Fig. 5 A). The depletion 
of either Nup decreased virus production (Nup62 KD, 23.7 ± 
18.6%; Nup107 KD, 43.0 ± 25.6%; Fig. 5 B). Nup62 KD also 
decreased virus infectivity to 54.8 ± 25% of wild-type levels, 
whereas  the  Nup107  KD  modestly  enhanced  infectivity  to 
134.3 ± 29%. It is important to add that, as shown in Figs. 2 A 
and 3 E, although HIV-1 infection lowers the abundance of both 
Nups at NEs, KD lowers total cellular levels. Additional cellular 
loss of Nup62 by HIV-1 may be a result of its encapsidation into 
viruses. The observation that Nup62 KD halves virus infectivity 
suggests that it has important roles in HIV-1 replication. Nup107 
KD may increase virus infectivity by causing more Nup62 to be 
available or by limiting the number of NPCs, thereby causing 
a temporal shift that blocks further nuclear import and that ac-
celerates viral expression and packaging.
We next examined the effects of Nup62 KD on vRNA local-
ization using IF/FISH (Fig. 5 C). In the control, nonsilencing 
condition, we observed thickened staining for Nup107 at NEs 
as we do for Nup62 in HIV-1–expressing cells. Because HIV-1 
does not cause a decrease in whole cell levels of Nup107, this 
staining likely represents Nup mislocalization at NPCs (Fig. 5 C,   
top row). The effects of the Nup62 KD are remarkable (Fig. 5 C,   
middle row). For one, the KD does not completely diminish 
Nup62 staining, which is suggested to be a result of preferen-
tial replenishment of an essential Nup62 pool (Fig. 5 C, middle 
row; Hubert et al., 2009). Even more striking is the fact that 
Nup62 KD causes the nuclear retention of the vRNA similar to 
what is observed in Rev() conditions (Fig. 4 C), providing an 
explanation for the dramatic reduction in Gag expression and 
viral production. Nup107 KD has no effect on vRNA localiza-
tion but does cause the improper positioning of Nup62, which 
accumulates at distinct perinuclear regions (Fig. 5 C, bottom 
row). In addition, under Nup107 KD, HIV-1 does not cause 
the same Nup62 staining pattern as in nonsilencing conditions, 
indicating that only properly positioned Nup62 at NPCs may 
become cytoplasmically diffused as a result of HIV-1 infection. 
Altogether, these results indicate that Nup62 is essential for 
vRNA export and virus infectivity and suggest that its role during 
HIV-1 replication begins at the nucleus.
Though our data suggest that Nups take leave of the NPC 
by virtue of their affinity to the Rev–vRNA RNP, other alterna-
tives are possible. For instance, NPC destabilization may result 
from the association of Nups and integrated proviral cDNA or 
nuclear vRNA during transcription (Capelson et al., 2010; Hou 
and Corces, 2010; Strambio-De-Castillia et al., 2010). HIV-1 
may disrupt NPCs to evade antiviral responses, as seen in other 
viruses (Gustin and Sarnow, 2002; Fontoura et al., 2005; Bardina 
et al., 2009; Porter and Palmenberg, 2009; Atasheva et al.,   
2010; Ren et al., 2010). Another possibility is that encapsidated 
Nup62 may be required for efficient delivery of the PIC into the 
nuclei of newly infected cells (Fig. 5 D). Consistently, Trans-
portin-SR2 (TRN-SR2/TNPO3), the importin found to be re-
sponsible for the nuclear import of the HIV-1 PIC, was found to 
bind exclusively to Nup62 (Lai et al., 2001; Christ et al., 2008). 
Lai et al. (2001) suggested that the import route used by TRN-
SR2 is distinct from that taken by other importins and that 
Nup62 may function as the docking site for TRN-SR2–cargo 
complexes at NPCs.627 HIV-1 remodels the nuclear pore complex • Monette et al.
Figure 5.  Nup62 is essential for vRNA nuclear export and virus infectivity. Mock- and HIV-1–transfected HeLa cells were depleted of Nup62 and Nup107 
using siRNA. (A) Western analysis for Nup62, Nup107, pr55
Gag, and Nucleolin (loading control). (B) Effects of Nup62 and Nup107 KDs on virus produc-
tion, TZM-bl FLuc activity, and infectivity. Protease() and Envelope() virus were used as negative infectivity controls. Error bars represent SD. (C) IF/FISH 
analysis of Nup62, Nup107, vRNA, DAPI, and DIC. Percentages in the vRNA column represent the frequency observed for each condition, and n = 500 
vRNA-positive cells in three independent experiments. Bars, 10 µm. (D) A predictive model on how viruses may exploit encapsidated Nup62. Integrated 
proviral DNA (green; 1) is transcribed into vRNA (squiggly green) that is then exported with Nup62 (purple) to the cytoplasm as an RNP (2). vRNA dimer-
izes and is encapsidated into budding virus (3) that can now infect new cells, in which Nup62 may promote efficient nuclear import of the PIC (4) and 
integration into the host DNA (5). Cyt, cytoplasm; NE, nuclear envelope; Nuc, nucleus; PM, plasma membrane.JCB • VOLUME 193 • NUMBER 4 • 2011   628
(Rockland  Immunochemicals);  Alexa  Fluor  fluorophore  conjugates  and 
DAPI (Invitrogen); and gold conjugates (Ted Pella, Inc.). The plasmids used 
in this study were pcDNA3.1 (Invitrogen); pNL4-3 and pMRev() (National 
Institutes of Health AIDS Reference and Reagent Program); pNL4-3 Rev() 
(R38Q; a gift from D. Purcell, University of Melbourne, Melbourne, Aus-
tralia); pNL4-3vif(), nef(), vpu(), and vpr() (a gift from K. Strebel, 
National Institute of Allergy and Infectious Diseases, National Institutes of 
Health, Bethesda, MD); pro() (a gift from M. Laughrea, McGill University, 
Montréal, Quebec, Canada); env(–) (Yao et al., 1998); pNL4-XX (a gift 
from D. Ott, National Cancer Institute, National Institutes of Health, Fred-
erick, MD); and RFP and Rev-RFP (provided by R. Brack-Werner, Helmholtz 
Zentrum München, Neuherberg, Germany). Nonsilencing control and siRNAs 
targeting  Nup62  (5-GCAACTGCTCCAACCTCAT-3)  and  siNup107 
(5-CAAATACTTCTTTTGCAGC-3) were purchased from QIAGEN.
Western, IF, FISH, and imaging analyses
For Western analysis, cells were collected at the indicated times after trans-
fection, washed with PBS (Invitrogen), and lysed in NTEN buffer (100 mm 
NaCl, 10 mm Tris, pH 7.5, 1 mm EDTA, 0.5% Nonidet P-40 Protease in-
hibitor cocktail [Roche], and RNaseOUT [Invitrogen]). Cell lysates were 
quantified for protein content by the micro Bradford assay (Bio-Rad Laborato-
ries), and equal quantities of protein were loaded into SDS-polyacrylamide 
gels. Proteins were then transferred onto nitrocellulose membranes (Pall), 
and blocked membranes were first incubated with primary antibodies 
of interest and then with secondary antibodies conjugated to HRP (Rock-
land Immunochemicals). The Western Lightning Chemiluminescence Re-
agent  Plus  kit  (PerkinElmer)  was  used  for  protein  detection  via  films 
(BioMax; Kodak).
IF and FISH analyses have been described previously (Bériault et al., 
2004; Lévesque et al., 2006; Lehmann et al., 2009). In brief, cells on 
coverslips were fixed in 4% PFA in PBS for 20 min followed by permea-
bilization with 0.2% Triton X-100 for 10 min at the indicated times after 
transfection.  All  reagents  used  were  treated  with  diethylpyrocarbonate 
(Sigma-Aldrich). For FISH analyses of the HIV-1 vRNA, coverslips were 
treated with DNase I (Invitrogen) for 30 min and washed. A digoxigenin-
labeled RNA probe was synthesized via in vitro transcription from the 
plasmid pKS-Pol236nt in the presence of digoxigenin-labeled UTP from the 
RNA Labeling Mix (Roche) and was annealed to permeabilized cells over-
night at 42°C. After hybridization, the vRNA was visualized by staining 
with a mouse antidigoxigenin antibody (Sigma-Aldrich) followed by stain-
ing with an Alexa Fluor fluorochrome-conjugated donkey IgG anti–mouse 
antibody (Invitrogen). For IF, coverslips were blocked with blocking reagent 
(Roche) in PBS before being incubated with primary antibodies against   
antigens of interest and then with secondary fluorophore-conjugated donkey 
IgG Alexa Fluor antibodies. Coverslips were stained with DAPI (Sigma-
Aldrich), dried, and mounted onto slides using a mounting medium (Immu-
mount; Thermo Fisher Scientific).
Images appearing in Figs. 1, 2, and 5 were acquired at RT using a 
microscope (DM16000B; Leica) equipped with a spinning disk confocal 
head (WaveFX; Quorum), a 63× (1.4 numerical aperture oil immersion) 
plan apochromat objective lens, and an EM charge-coupled device camera 
(ImageEM;  Hamamatsu  Photonics).  Volocity  Imaging  software  (v4.3.2; 
PerkinElmer) was the acquisition software used to acquire images, in which 
Alexa Fluor 633, 594, and 488 antibody fluorochromes and DAPI were 
scanned using excitation wavelengths of 646, 561, 491, and 405 nm, and 
emission spectra were filtered with 665–715-, 570–620-, 500–550-, and 
435–485-nm bandpass filters, respectively and sequentially. Images ap-
pearing in Fig. 4 were acquired at RT using a laser-scanning confocal mi-
croscope (LSM 5 PASCAL; Carl Zeiss) equipped with a 63× (1.4 numerical 
aperture oil immersion) plan apochromat objective lens and an Ar/Kr laser. 
The acquisition software used was LMS Image Browser (Carl Zeiss), in 
which  Alexa  Fluor  633,  594,  and  488  antibody  fluorochromes  were 
scanned using excitation wavelengths of 633, 543, and 488 nm, and emis-
sion spectra were filtered with 650-, 560–615-, and 505–530-nm long- 
and bandpass filters, respectively and sequentially. Images were recorded 
at a thickness of 1 µm (z stacks were taken at 0.2-µm intervals) and were 
digitized at a resolution of 1,024 × 1,024 pixels. AutoDeblur software 
(Autoquant; Media Cybernetics) was used for deconvolution of Fig. 4 (A 
and B). The LSM (Carl Zeiss) and Liff (Volocity; PerkinElmer) files were 
imported into Imaris software (v7; Bitplane) for pseudocoloring of channels, 
3D reconstitutions of z stacks, colocalization analysis using Mander’s coeffi-
cient, and image export for figure montage in Illustrator (CS3; Adobe).
LC-MS/MS analysis
Coomassie blue–stained SDS-PAGE LC-MS/MS analysis was performed 
as previously described (Zulak et al., 2009). In brief, gel plugs were 
In this study, we find that several Nups are decreased at 
NEs by HIV-1 infection and that at least one of them is essential 
for HIV-1 replication and virus infectivity. Because HIV-1 re-
quires Nups for the nuclear entry of the PIC, the nuclear export 
of the vRNA RNP, and for virus infectivity, the prospect of tar-
geting the interacting protein domains of Nups and viral com-
ponents against HIV-1 propagation may be even more effective 
than is presently considered, and targeting the right Nup may 
bring the HIV-1 replication cycle to a halt.
Materials and methods
Cell culture and transfections
HeLa  and  HeLa–TZM-bl  cells  grown  in  DME  supplemented  with  FBS   
(Invitrogen) or CD4
+/CXCR4
+ Jurkat CE6.1 T cells (American Type Culture 
Collection) were grown in RPMI 1640 media supplemented with 10% FBS 
(Invitrogen). Cells were transfected with 1 µg/ml plasmid DNA and/or 
100 nM siRNA using Lipofectamine 2000 (Invitrogen). HeLa cells were 
collected 24 h later unless otherwise indicated. T cells were counted and 
reseeded at 300,000/ml every 3 d until peak infection at day 12 after 
transfection. For imaging studies, HeLa cells were seeded onto sterile 
coverslips, and, for T cells, sterile poly-l-lysine–coated (Sigma-Aldrich) cover-
slips were dropped into wells, and cells were allowed to settle onto these for 
1 h before fixing with 4% PFA.
NE isolation
A recently published technique was used for NE isolation (Korfali et al., 
2009). In brief, equal numbers of mock- and peak-infected T cells were col-
lected,  washed  with  PBS,  incubated  in  hypotonic  lysis  buffer  (10  mM 
Hepes, pH 7.4, 1.5 mM MgCl2, and 10 mM KCl) for 10 min, Dounce ho-
mogenized (40-ml capacity Wheaton type; VWR), and resuspended in 2.2 M 
SHKM (2.2 M sucrose, 50 mM Hepes, pH 7.4, 25 mM KCl, and 5 mM 
MgCl2). The lot was transferred to 38.5-ml ultracentrifuge tubes (Beckman 
Coulter), underlayed with 30% SHKM (0.9 M sucrose, 50 mM Hepes,   
pH 7.4, 25 mM KCl, and 5 mM MgCl2), and centrifuged at 4,000 rpm for 
20 min at 4°C (SW28 Ti Rotor; Beckman Coulter). Pellets were resuspended 
in 1.8 M SHKM and were underlayed with 2.2 M SHKM for centrifugation 
at 25,000 rpm for 2.5 h at 4°C. Pellets were resuspended in 0.25 M 
SHKM (50 mM Hepes, pH 7.4, 25 mM KCl, and 5 mM MgCl2), treated 
with RNase A and DNase I (Invitrogen) for 15 min, and resuspended in 
10% SHM (0.3 M sucrose, 10 mM Hepes, pH 7.4, and 2 mM MgCl2) for 
centrifugation at 5,000 rpm for 10 min at 4°C. Pellets were resuspended 
in 10% SHM, again treated with RNase A and DNase I for 15 min, under-
layed with 30% SHM, and centrifuged at 5,000 rpm for 30 min at 4°C. 
Pellets were resuspended in 1 ml of 10% SHM, aliquoted, and centrifuged 
at 8,000 rpm for 10 min at 4°C, after which the supernatant was aspi-
rated, and pellets were stored at 80°C until further processing. All solu-
tions had 2 mM of fresh DTT and protease inhibitor (Roche) added to them. 
For salt extractions yielding higher numbers of Nups in mass spectrometry, 
pellets were resuspended in 0.25 M SHKM containing 1 M NaCl (Dreger 
et al., 2001; Schirmer and Gerace, 2005), incubated on a rotating plat-
form for 30 min at 4°C, and centrifuged at 8,000 rpm for 10 min at 4°C, 
after which the supernatants were aspirated. For IF analyses of products 
from  the  NE  isolations,  20  µl  of  material  obtained  at  each  step  was 
dropped at the center of poly-d-lysine–treated coverslips, sandwiched by 
another nontreated coverslip, and incubated for 1 h at 4°C before fixation 
with 4% PFA. NE isolations were performed seven times, and IF experi-
ments were performed four times.
Antibodies, plasmids, and siRNA sequences
The following antibodies were used in this study: –p24 CA (a gift from 
M. Phelan, National Institutes of Health AIDS Reference and Reagent Pro-
gram, Germantown, MD); cleaved –Caspase-3 (a gift from J. Galipeau, 
McGill University, Montréal, Quebec, Canada); –Lamin B1 (a gift from   
V. Blank, McGill University, Montréal, Quebec, Canada); -RHA (a gift 
from J. Ortin, Universidad de Madrid, Madrid, Spain); -Gp210 (a gift 
from D. Görlich and K. Paulsen, Max Planck Institute for Biophysical Chem-
istry, Göttingen, Germany); -GAPDH (Techni-Science, Inc.); –ERGIC-53 
and -Nup62 (Sigma-Aldrich); -Actin, -eIF4E, -eIF2, –Transportin-1, 
-Nup107, QE5, and mab414 (Abcam); –CA p24 (ABT-Trinity Bio-
technology);  -Nucleolin  and  -PCNA  (Santa  Cruz  Biotechnology, 
Inc.);  -Calnexin  (Stressgen);  -L7  (Novus  Biologicals);  HRP  conjugates   629 HIV-1 remodels the nuclear pore complex • Monette et al.
Cells exhibiting virus particles at their plasma membranes were those used 
for assessment of NE structure and gold labeling from HIV-1 expression. 
Imaris software was used to measure particle distances from the inner nu-
clear membrane.
Virus purification
Supernatants were collected from mock- or pNL4-3–transfected HeLa and 
T cells and were clarified by centrifugation at 2,000 g for 10 min at 4°C 
followed by filtration (0.2 µm). These were then underlayed with a 20% 
wt/vol sucrose and centrifuged at 125,000 g for 1 h at 4°C. Virus pellets 
were resuspended in TNE buffer (10 mM Tris-HCl, pH 8.0, 100 mM NaCl, 
and 2 mM EDTA) and separated using SDS-PAGE.
Virus infectivity assay
CD4
 HeLa cells were transfected with 100 nM siRNAs for 24 h and were 
then cotransfected with siRNAs and mock or pNL4-3, Pro(), or Env() 
proviral DNAs. 48 h later, cells were collected for Western analysis, and 
supernatants were processed as described in the previous section before 
being added to growing TZM-bl CD4
+ cells containing Tat-inducible Fluc 
reporter. At 24 h after infection (Kim et al., 1989), TZM-bl cells were lysed 
in passive lysis buffer for Fluc activity according to the manufacturer (Pro-
mega). Virus from supernatants was quantified using the HIV-1 p24 Cap-
ture  ELISA  kit  (Advanced  BioScience  Laboratories,  Inc.).  Infectivity  was 
determined by dividing Fluc activity by virus concentration.
Online supplemental material
Table S1 shows identified NE-associated proteins that interact with HIV-1 
proteins or the vRNA, and Table S2 shows identified NE-associated pro-
teins with known functions during HIV-1 replication. Table S3 shows all 
proteins identified by LC-MS/MS with associated emPAI values in the last 
column.  Online  supplemental  material  is  available  at  http://www.jcb 
.org/cgi/content/full/jcb.201008064/DC1.
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